FDA Panel Backs 2 Hepatitis C Drugs
A major advance for treating hepatitis C is likely headed to market after government advisors backed two new drugs: telaprevir and boceprivir.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.